Collaborating with CROs within the DMTA cycle

Posted by
András Strácz
on 13 10 2021

Important factors when collaborating with a CRO

It is becoming increasingly popular for drug discovery companies to outsource parts of the DMTA process to Contract Research Organizations (CROs). This puts a higher pressure on the project leader, who needs to keep track of both in house and external activities. Having all project-related information such as data, status of ongoing activities and upcoming plans for both internal and external project members collected in one place facilitates the overview and communication.

LEARN MORE ABOUT DESIGN HUB